Board of Directors
Shahrokh Shabahang, D.D.S., M.S., Ph.D.
Dr. Shahrokh Shabahang is a co-founder and President of SEKRIS Biomedical, Inc. Dr. Shabahang received his DDS in 1987 from University of Pacific, an endodontic certificate and MS in 1997 from Loma Linda University, and a PhD in Microbiology and Molecular Genetics from Loma Linda University in 2001.
During his tenure as a member of the faculty at Loma Linda University, he maintained a laboratory with emphasis on the effects of local infections on systemic diseases. In 2005, Dr. Shabahang transitioned from academia to industry and has dedicated his time to development of novel biological therapeutic agents from the proof-of-concept stage in the laboratory to clinical trials.
His combined background in clinical practice, basic and clinical research, understanding of the regulatory approval process and company financing have helped Dr. Shabahang to lead the company efforts in developing a path to the clinic and commercialization of the SEKRIS technology.
Leonard L. Bailey, M.D.
Dr. Leonard Bailey developed a vision for infant heart transplantation during his residency program when he saw that otherwise perfect babies were dying from hypoplastic left heart syndrome – a congenital heart defect that defied successful reconstructive heart surgery.
He performed over 200 experimental transplantations in infant research animals at Loma Linda University to determine the feasibility of transplantation in the very young before his first human transplantation in October 1984 when he transplanted a baboon heart into the infant known as Baby Fae.
In November 1985, he performed the first successful human to human heart transplantation in a newborn baby. Transplantation remains a small portion of Dr. Bailey’s practice, which involves all types of congenital heart disease in all age groups. With many scientific publications, Dr. Bailey is an internationally recognized authority on congenital heart surgery and infant heart transplantation. He lectures and operates regularly throughout the world.
He is the Distinguished Professor of Surgery of Loma Linda University School of Medicine and Surgeon-in-Chief of Loma Linda University Children’s Hospital. Dr. Bailey lives in Southern California with his wife Nancy. They have two sons.
Joachim-Friedrich Kapp, M.D., Ph.D.
Dr. Joachim-Friedrich Kapp joined Schering AG, Germany, in 1975 as a scientist in the Department of Inflammation Research and Immunology. He became Section Head in 1976 and Department Head in 1977.
In 1980 he transferred as Medical Director to Schering’s newly acquired US subsidiary, Berlex, and was appointed Vice President and Head of Research and Development in 1981.
From 1984 through 1990 he was with Warner-Lambert’s German subsidiary Goedecke, first as Medical Director, from 1985 on as Head of Research and Development, and in 1988 he was appointed Vice President of Warner-Lambert’s International Clinical Development. In 1991, Dr. Kapp returned to Schering as President of the Global Business Unit Therapeutics.
After retiring from Schering in October 2005, Dr. Kapp has been serving on a number of Boards of Pharmaceutical and Biotech companies. Dr. Kapp is Board certified in Pharmacology and Toxicology as well as in Clinical Pharmacology.
Saeed Kamali, M.D., M.B.A.
After completing his residency in Anesthesiology at Harvard University as Chief Resident, Dr. Kamali has operated a practice since 2002. Post residency, Dr. Kamali joined St. Jude Medical Center in Fullerton, CA as a staff anesthesiologist.
In 2005, he made a transition to sole practitioner in Newport Beach, CA specializing in complicated outpatient cases.
Seeing an unfulfilled need, Dr. Kamali has focused on complex outpatient bariatric procedures. While actively practicing anesthesiology, in 2013 Dr. Kamali endeavored to broaden his understanding of the business of medicine and obtained an MBA with an emphasis on Health Care at the University of California, Irvine.
Presently, Dr. Kamali is a practicing board certified anesthesiologist while taking an active role in multiple medical related start-ups which he feels will better the science and practice of medicine.
Neusha Ghassemian, B.A.
Mr. Neusha Ghassemian graduated from University of California, Riverside with a BA in Economics.
Currently, he engages in research projects at UCLA Harbor Medical Center and is actively involved with a company in the pharmacy industry.
Mr. Ghassemian has volunteered for the LA County Sheriffs’ Department and at regional hospitals.
Mr. Ghassemian joined the SEKRIS Board of Directors in 2015 representing shareholders and acting as an external board member.